Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
The purpose of the study: to assess the morphological changes in the lungs depending on the content of clozapine and its metabolites in the lungs and serum.Materials and methods. The experiments were performed on male outbred rats weighing 290-350 g at the age of 20 weeks (n=15). The animals were divided into 3 groups: Group 1 — reference group (intact rats) (n=5); Group 2 -poisoning with clozapine (n=5); Group 3 — poisoning with a combination of clozapine with ethanol (n=5). Clozapine was administered orally at a dose of 150 mg per kg of animal's body weight under general anesthesia; alcohol was administered together with clozapine orally at a dose of 5 ml per kg of animal's body weight. Further study was carried out 24 hours after administration of drugs to animals of the 2nd and 3rd groups. After euthanasia of the animals by decapitation, tissue samples of lungs were embedded in paraffin according to the standard technique. Then 5-μm thick histological sections were made and examined using light microscopy with the aid of a Nikon Eclipse E400 microscope equipped with a video system based on the Watec 221S camera (Japan) at magnification of X200 and X400. The following pathological patterns were assessed: disorder of blood circulation (hyperemia, hemorrhage, and sludge), the presence of atelectasis and dystelectasis, the presence of emphysema, the cellular response (an increase in the white blood cell count), and desquamation of epithelium into the lumen of the bronchi. A chemical and toxicological study was performed on a high-performance liquid chromatograph with mass detector Agilent Technologies 430 Triple Quad LC/MS (Germany). To obtain chromatograms, the following software was used: Agilent Mass Hunter Workstation for series tripple Quadrapole vers. B06.00 build 6.0.6.25.4sp4.The following software was used for processing chromatograms: Agilent Mass Hunter Quantitive Analysis vers. B 07.00 build 7.0.457.0. Serum and lung homogenate levels of clozapine, norclozapine, and clozapine-N — oxide were evaluated.Results. In 24 hours, animals in the 2nd group exhibited atelectasis and dystelectasis in the lung tissue, and leukocyte infiltration; in the 3rd group, arterial hyperemia, cellular response (an increase in the white blood cell count), atelectasis and dystelectasis, and thickening of interalveolar septa were revealed. In 24 hours, in the lungs of animals of the 3rd group, the concentration of clozapine increased by 22.2-fold, norclozapine by 6.6-fold, and clozapine-Noxide by 6.2-fold as compared to the 2nd group; in serum it increased by 5.7-, 2.0and 4.6-fold, respectively.Conclusion. In the case of poisoning with clozapine in combination with ethanol, a complex of pathological changes in the lungs develops, which is more severe than the isolated effect of clozapine administered as a single drug. The concentration of clozapine and its metabolites in the lung tissue and blood serum is higher when it enters the body in combination with ethanol.
The purpose of the study: to assess the morphological changes in the lungs depending on the content of clozapine and its metabolites in the lungs and serum.Materials and methods. The experiments were performed on male outbred rats weighing 290-350 g at the age of 20 weeks (n=15). The animals were divided into 3 groups: Group 1 — reference group (intact rats) (n=5); Group 2 -poisoning with clozapine (n=5); Group 3 — poisoning with a combination of clozapine with ethanol (n=5). Clozapine was administered orally at a dose of 150 mg per kg of animal's body weight under general anesthesia; alcohol was administered together with clozapine orally at a dose of 5 ml per kg of animal's body weight. Further study was carried out 24 hours after administration of drugs to animals of the 2nd and 3rd groups. After euthanasia of the animals by decapitation, tissue samples of lungs were embedded in paraffin according to the standard technique. Then 5-μm thick histological sections were made and examined using light microscopy with the aid of a Nikon Eclipse E400 microscope equipped with a video system based on the Watec 221S camera (Japan) at magnification of X200 and X400. The following pathological patterns were assessed: disorder of blood circulation (hyperemia, hemorrhage, and sludge), the presence of atelectasis and dystelectasis, the presence of emphysema, the cellular response (an increase in the white blood cell count), and desquamation of epithelium into the lumen of the bronchi. A chemical and toxicological study was performed on a high-performance liquid chromatograph with mass detector Agilent Technologies 430 Triple Quad LC/MS (Germany). To obtain chromatograms, the following software was used: Agilent Mass Hunter Workstation for series tripple Quadrapole vers. B06.00 build 6.0.6.25.4sp4.The following software was used for processing chromatograms: Agilent Mass Hunter Quantitive Analysis vers. B 07.00 build 7.0.457.0. Serum and lung homogenate levels of clozapine, norclozapine, and clozapine-N — oxide were evaluated.Results. In 24 hours, animals in the 2nd group exhibited atelectasis and dystelectasis in the lung tissue, and leukocyte infiltration; in the 3rd group, arterial hyperemia, cellular response (an increase in the white blood cell count), atelectasis and dystelectasis, and thickening of interalveolar septa were revealed. In 24 hours, in the lungs of animals of the 3rd group, the concentration of clozapine increased by 22.2-fold, norclozapine by 6.6-fold, and clozapine-Noxide by 6.2-fold as compared to the 2nd group; in serum it increased by 5.7-, 2.0and 4.6-fold, respectively.Conclusion. In the case of poisoning with clozapine in combination with ethanol, a complex of pathological changes in the lungs develops, which is more severe than the isolated effect of clozapine administered as a single drug. The concentration of clozapine and its metabolites in the lung tissue and blood serum is higher when it enters the body in combination with ethanol.
The article is devoted to the analysis of literature data on the use of hyperbaric oxygenation (HBO) in patients with COVID-19, complicated by the development of SARS-CoV-2-associated pneumonia to build a hypothesis about possible mechanisms of therapeutic action of hyperbaric oxygen (HBO2) in this pathology. The expediency of using «soft» (1.3–2.0 attacks, 40–60 min) HBO modes in SARS-CoV-2-associated pneumonia is substantiated. Several possible mechanisms of elimination of HBO2 violation of lung gas exchange function in SARS-CoV-2-associated pneumonia are considered. Firstly, hyperoxic stimulation of diaphragm contraction. Secondly, the inhibitory effect of HBO2 on the development of interstitial and alveolar edema in the lungs. Thirdly, elimination of HBO2 stimulating effect of thrombin and fibrinogen on contractility of pulmonary capillary endotheliocytes. Fourth, regulation of HBO2 metabolism of fibronectin, thromboplastin, von Willibrant factors, and platelet activation factor in the wall of pulmonary capillaries. As a result, its thrombogenic activity increases in this pathology.
The paper summarizes data on modern approaches to the diagnosis, prevention and treatment of severe acute parenchymal respiratory failure of various origins, including ARDS due to bacterial viral pneumonia. The work is based on the data of modern well-organized studies, analysis of international clinical guidelines with a high degree of evidence, as well as the results of our own long-term experimental studies and clinical observations of the treatment of patients with ARDS of various origins, including viral pneumonia of 2009, 2016, 2020. Scientifically grounded algorithms for prevention, differential diagnosis and personalized therapy of severe acute respiratory failure using innovative medical technologies and a wide range of respiratory and adjuvant treatment methods have been formulated. The authors tried to adapt as much as possible the existing current recommendations for the daily clinical practice of anesthesiologists and resuscitators.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.